VPS41 and Parkinson disease: VPS41 was previously reported to confer neuroprotection in both C. elegans and mammalian models for Parkinson’s disease (Hamamichi etal, 2008; Ruan etal, 2010; Harrington etal, 2012; Griffin etal, 2018).